Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Eisai files for Japanese approval of AD treatment agent

Aug. 17, 1998

Gidazepam, a new benzodiazepine anxiolytic with potential in asthenic disorders

Aug. 17, 1998

Unique agent for cognition disorders: GTS-21, a nicotinic acetylcholine agonist

Aug. 17, 1998

New cerebroprotective agents described by Japanese team

Aug. 17, 1998

Muscle-relaxant activity of silperisone: comparison with lidocaine

Aug. 14, 1998

Analben, a non-narcotic analgesic in phase II testing

Aug. 14, 1998

Known antiischemic agent demonstrates cognition-enhancing effects

Aug. 14, 1998

Three studies confirm efficacy and safety of Chinese AD treatment agent

Aug. 14, 1998

French team discloses newly discovered 5-HT1A agonists

Aug. 14, 1998

Phase III trial of Ampligen for the treatment of CFS now underway

Aug. 14, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...